[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Select Biosciences Ltd.: Market Research Reports

Select Biosciences Ltd. (SELECTBIO) was created in 1999 to offer focused market reports, recruitment, customised consultancy, training conferences and courses to the life sciences domain. The company’s Market Reports department is busy with creating specialist reports that assess major developments in leading-edge fields as they start to expand. The research studies are focused on analysing the emerging and dynamic markets in the drug discovery and life sciences fields. In case there is a specific requirement for a report, SELECTBIO’s experts are willing to do everything they can to make sure these requirements are met in full.

The company’s market reports provide an all-round analysis of the industry, a review of technologies utilised, insights into the market trends and opportunities, market share information, market size data and expected growth rates, etc.

Market reports developed by SELECTBIO encompass a wide range of areas, such as the stem cells domain; emerging classes of diagnostics; biomarkers, pharmacogenetics and personalised medicine; therapeutic proteins, antibodies and vaccines; reagents for life science research, instrumentation and consumables; microRNAs and epigenetics; omics technologies; bioprocessing, biotherapeutics (or biologics) and biosimilars; drug discovery technologies and tools; and systems biology, among others.

Publications found: 16
Sort by:

Mass Spectrometry for Clinical Diagnostics Applications 2013 Focus Report

US$ 1,318.00

... ) and In vitro Diagnostics (IVDs) based on Mass Spectrometry CLIAC Recommendations Collaborations and Partnerships in the Mass Spectrometry for Clinical Diagnostics Space Pipeline of Grants Awarded for Technology Development in the Mass Spectrometry for Clinical Diagnostics Space Mass Spectrometry and ...

June 2013 73 pages

Epigenetic and MicroRNA Biomarkers 2013 Market Report

US$ 2,000.00

This market report from SELECTBIO represents the most up-to-date analysis of the Epigenetic and MicroRNA Biomarkers spaces together with research market data [qualitative and quantitative analysis] characterizing the epigenetics and microRNA research fields

June 2013 118 pages

Cellular Therapy and Cord Blood 2013 Market Report

US$ 2,119.00

... is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences. In this ... . Select Biosciences has also provided a detailed quantitative analysis of the cord blood field as it is rapidly evolving. Our coverage provides hard numbers ...

January 2013 172 pages

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2013

US$ 2,119.00

... and CSCs Technologies for Studying CTCs CTC Analysis Workflow Enrichment and Analysis Methodologies Details of Selected Approaches for CTC Enumeration and Analysis Name of Company/Institution Microfluidics-based Approaches Imaging-based Approaches CTC and CSC Research Market ...

December 2012 155 pages

Companion Diagnostics and Personalized Medicine Market Report 2012

US$ 2,119.00

... Report is written and delivered to customers in PowerPoint format. Extensive Market Analyses Presented in this Report Personalized Medicine and Companion Diagnostics: Market Segmentation and Quantitative Analysis Prognostic Biomarkers in Cancer Listing, Description, and Clinical Significance Predictive ...

July 2012 130 pages

MicroRNAs and Exosomes Market Report 2012

US$ 2,119.00

... market tracking wherein we’ve analyzed end-user research trends in the microRNA as well as Exosome markets—these areas are evolving in parallel given the opportunity in ... and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business ...

July 2012 168 pages

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2012

US$ 1,655.00

... and CSCs spaces including: Surface markers currently used to study CTCs and CSCs Intracellular signaling pathways analyzed in CSCs Quantitative Breakout ... EMT Signaling Pathways and Molecular Effectors Markers for CSCs Circulating Tumor Cells (CTCs) Research Approaches Methodologies for Study/Analysis ...

December 2011 122 pages

MicroRNA Market Trends 2011

US$ 1,655.00

... from the bottom-up. This report analyzes the microRNA marketplace from a market perspective describing the market trends operative in this space, quantitative penetrance of ... they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business ...

September 2011 139 pages

Algae Biofuel: Why Not Now?

US$ 1,589.00

... large-scale culture systems need further “standardization” to enable a large-scale algae biofuel industry to break out, and even here a limited number of ... companies where intellectual property enhancements might exist. When a large scale algae biofuel industry does break out, we also believe that winners ...

August 2011 87 pages

Circulating Tumor Cells (CTCs) Market Trends 2011

US$ 1,589.00

This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) space. In this report, we focus upon the emerging marketplace for the isolation and study of CTCs, a potentially important tool for cancer diagnostics with special relevance to ...

June 2011 89 pages

Emerging Pharmaceutical Markets 2012

US$ 3,907.00

... to strong performance in the emerging pharmaceutical markets, the global pharmaceutical market is expected to reach US$ 1,020 Billion by the end of 2012. This research ... therapeutic segments, different and complex regulatory law and a fragmented market. The worldwide economic crisis has also added a new layer ...

May 2011 222 pages

Umbilical Cord Blood Banking Market Trends 2011

US$ 1,323.00

... , utilization trends of cord blood for different diseases in different countries of the world. This report analyzes the umbilical cord blood marketplace ... and associated qualitative trends. This data-driven characterization of the cord blood banking market landscape is a hands-on document that can be used for ...

May 2011 42 pages

Single Cell Omics 2011

US$ 3,907.00

... that will enable researchers to generate more data from smaller numbers of cells, which can be enabling in cases of precious samples. The result of this ... of the fittest requires a detailed understanding of this emerging market. Single Cell Omics 2011 explains the key technologies, applications, unmet needs ...

April 2011 167 pages

Cancer Vaccines & Circulating Tumor Cells (CTCs) 2011 Report

US$ 2,649.00

... Biosciences presents a comprehensive industry analysis of the cancer vaccines space as well as that of the emerging circulating tumor cells (CTCs) space. These two ... This report also examines the technology and market landscape for circulating tumor cells (CTCs). There is currently much interest in CTCs as they ...

December 2010 139 pages

Epigenetics Market Trends 2011

US$ 1,655.00

... Market Quantitative Segmentation by type of Modification Studied Epigenetics Market Segmentation by Type of HDAC Studied Penetrance of Product Vendors into Various Segments of the Epigenetics Marketplace: Quantitative Analysis Emerging Trends and Themes in Epigenetics Current Studies of microRNAs, non- ...

December 2010 76 pages

Adult Stem Cells Market Trends 2011

US$ 1,986.00

... analyzes the umbilical cord blood marketplace from a technical as well as market perspective describing the types of transplantation utilizing cord blood, disease ... into stem cell research trends (both qualitative and quantitative). This data-driven characterization of the adult stem cells market landscape ...

December 2010 100 pages